Radiotherapy Market
Radiotherapy Market Size, Share & Trends Analysis Report, By Product Type (External Beam Radiotherapy Systems, Brachytherapy Systems, Radiotherapy Software, Radiotherapy Accessories), By Technology (IMRT, IGRT, SRT/SBRT, Proton Therapy, 3D-CRT), By Application (Breast Cancer, Lung Cancer, Prostate Cancer, Others), By End User (Hospitals, Radiotherapy Centers, Academic Institutes), Forecast Period (2026–2035)
Industry Overview
Radiotherapy market size was valued at $8.08 billion in 2025 and is projected to reach $13.65 billion by 2035, growing at a CAGR of 6.0% during 2026–2035. The market is witnessing steady expansion due to the rising prevalence of cancer, technological advancements in treatment systems, and increasing healthcare investments globally. Cancer remains one of the leading causes of death worldwide. According to the World Health Organization, approximately 10 million deaths were attributed to cancer in 2022, with incidence rates expected to grow significantly over the next decade. Radiotherapy plays a critical role in cancer treatment, being used in nearly 50–60% of cancer cases, which directly drives market demand.
Key end-use industries include hospitals, specialized radiotherapy centers, and academic research institutes. The growing adoption of precision medicine, combined with increasing investments in advanced technologies such as proton therapy and AI-based treatment planning, is further fueling market growth. Additionally, the rise in aging populations globally is contributing to increased cancer incidence, strengthening long-term demand for radiotherapy systems.
Market Dynamics
Rising Global Cancer Burden Driving Radiotherapy Demand
The primary driver of the radiotherapy market is the increasing global cancer burden and expanding treatment demand. According to the International Agency for Research on Cancer, global cancer cases are expected to reach over 35 million by 2050, representing a 77% increase compared to 2022 levels. This surge is significantly increasing demand for radiotherapy infrastructure worldwide.
Governments and healthcare organizations are investing heavily in oncology infrastructure. For instance, several countries are expanding national cancer programs and increasing access to radiotherapy systems. Additionally, the adoption of advanced technologies such as IMRT, IGRT, and proton therapy is improving treatment outcomes, thereby accelerating demand.
Leading companies are focusing on product innovation and geographic expansion in 2025–2026, targeting emerging markets such as India, China, and Southeast Asia, where cancer incidence is rising rapidly. These strategies are expected to enhance accessibility and drive market growth over the forecast period.
High Cost and Infrastructure Limitations Restraining Market Growth
Despite strong growth prospects, the radiotherapy market faces significant challenges related to high capital investment and infrastructure requirements. Advanced radiotherapy systems such as proton therapy can cost hundreds of millions of dollars, limiting adoption, especially in low- and middle-income countries.
According to the World Health Organization, many developing regions face limited access to radiotherapy services, with some countries having less than one radiotherapy machine per million people. This creates a substantial treatment gap and restricts market expansion.
Additionally, operational complexities, including the need for skilled professionals and maintenance requirements, further increase total cost of ownership. Supply chain disruptions and regulatory approvals also impact deployment timelines. However, companies are addressing these challenges by developing compact and cost-effective radiotherapy systems, improving accessibility and supporting broader adoption globally.
Market Segmentation
- Based on the product type, the market is segmented into external beam radiotherapy systems, internal radiotherapy systems, radiotherapy software, and radiotherapy accessories.
- Based on the technology, the market is segmented into IMRT, IGRT, SRT/SBRT, proton beam therapy, and 3D-CRT.
- Based on the application, the market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, head & neck cancer, brain tumors, cervical cancer, and others.
- Based on the end user, the market is segmented into hospitals, independent radiotherapy centers, and academic & research institutes.
External Beam Radiotherapy Systems Segment Leads the Market
The External Beam Radiotherapy (EBRT) Systems segment dominates the global market due to its widespread application across multiple cancer types. EBRT systems, including linear accelerators (LINACs), are widely used for treating breast, lung, and prostate cancers due to their precision and effectiveness. The demand is driven by increasing cancer cases and advancements in imaging-guided technologies such as IMRT and IGRT. Between 2022 and 2026, manufacturers have focused on enhancing system capabilities through AI integration, real-time imaging, and automation, improving treatment accuracy and patient outcomes. Hospitals and large cancer centers are major adopters of EBRT systems due to their ability to handle high patient volumes efficiently. Additionally, ongoing investments in oncology infrastructure globally are further strengthening the dominance of this segment.
Proton Beam Therapy Segment to Record Strong Growth
The Proton Beam Therapy segment is expected to witness the fastest growth during the forecast period due to its superior precision and reduced side effects compared to conventional radiotherapy. This technology is gaining traction for treating complex tumors, particularly in pediatric and brain cancers. Increasing investments in proton therapy centers and technological advancements are driving adoption. Companies are also focusing on developing compact proton therapy systems, reducing installation costs and expanding accessibility. Emerging markets are witnessing increased adoption due to government initiatives and private sector investments. The growing emphasis on personalized medicine and improved treatment outcomes is expected to further accelerate growth in this segment.
Regional Outlook
The global radiation therapy market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).
United States Leads the Market
The United States dominates the radiotherapy market due to advanced healthcare infrastructure and high adoption of cutting-edge technologies. According to the U.S. Food and Drug Administration, there has been a steady increase in approvals for innovative oncology devices, supporting market growth.
Additionally, strong healthcare expenditure and the presence of leading manufacturers contribute to widespread adoption of radiotherapy systems. The country also benefits from a high prevalence of cancer cases, further driving demand for advanced treatment solutions.
China to Record Strong Growth
China is expected to witness rapid growth in the radiotherapy market due to increasing healthcare investments and expanding oncology infrastructure. According to the World Health Organization, China accounts for a significant share of global cancer cases, creating substantial demand for radiotherapy services.
Government initiatives aimed at improving cancer care and increasing access to advanced medical technologies are supporting market expansion. Additionally, domestic manufacturing capabilities and rising healthcare spending are further accelerating adoption.
Competitive Landscape
The global radiotherapy market is highly competitive, with key players focusing on innovation, strategic collaborations, and geographic expansion to strengthen their market position. Leading companies such as Varian Medical Systems (Siemens Healthineers), Elekta AB, Accuray Incorporated, IBA (Ion Beam Applications S.A.), and ViewRay Technologies are investing in advanced radiotherapy technologies, including AI-based treatment planning and proton therapy systems. These companies are also expanding their presence in emerging markets to capitalize on growing demand.
Recent Developments
- In February 2025, Ion Beam Applications signed an agreement with Asian Institute of Gastroenterology to install a Proteus ONE proton therapy system in Hyderabad, India.
The contract includes system supply and a quality assurance package, with advanced DynamicARC capabilities planned post-approval. This deal highlights growing demand for proton therapy in India and strengthens IBA’s regional presence. - In November 2023, Mevion Medical Systems was selected by BayCare to install a MEVION S250-FIT Proton Therapy System at St. Joseph’s Hospital in Tampa.
The project supports BayCare’s expansion of advanced cancer treatment capabilities.
This reflects continued adoption of compact proton therapy solutions in the U.S. healthcare system.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global radiotherapy market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Radiotherapy Market Sales Analysis – Product Type | Technology | Application | End User ($ Million)
- Radiotherapy Market Sales Performance of Top Countries
1.1 Research Methodology
- Primary Research Approach
- Secondary Research Approach
1.2 Market Snapshot
- Market Overview and Insights
2.1 Scope of the Study
2.2 Analyst Insight & Current Market Trends
2.2.1 Key Radiotherapy Market Trends
2.2.2 Market Recommendations
2.3 Porter's Five Forces Analysis for the Radiotherapy Market
2.3.1 Competitive Rivalry
2.3.2 Threat of New Entrants
2.3.3 Bargaining Power of Suppliers
2.3.4 Bargaining Power of Buyers
2.3.5 Threat of Substitutes
- Market Determinants
3.1 Market Drivers
3.1.1 Drivers For Global Radiotherapy Market: Impact Analysis
3.2 Market Pain Points and Challenges
3.2.1 Restraints For Global Radiotherapy Market: Impact Analysis
3.3 Market Opportunities
3.3.1 Opportunities For Global Radiotherapy Market: Impact Analysis
- Competitive Landscape
4.1 Competitive Dashboard – Radiotherapy Market Revenue and Share by Manufacturers
- Radiotherapy Product Comparison Analysis
- Top Market Player Ranking Matrix
4.2 Key Company Analysis
4.2.1 Varian Medical Systems
4.2.1.1 Overview
4.2.1.2 Product Portfolio
4.2.1.3 Financial Analysis
4.2.1.4 SWOT Analysis
4.2.1.5 Business Strategy
4.2.2 Elekta AB
4.2.2.1 Overview
4.2.2.2 Product Portfolio
4.2.2.3 Financial Analysis
4.2.2.4 SWOT Analysis
4.2.2.5 Business Strategy
4.2.3 Accuray Incorporated
4.2.3.1 Overview
4.2.3.2 Product Portfolio
4.2.3.3 Financial Analysis
4.2.3.4 SWOT Analysis
4.2.3.5 Business Strategy
4.2.4 IBA (Ion Beam Applications S.A.)
4.2.4.1 Overview
4.2.4.2 Product Portfolio
4.2.4.3 Financial Analysis
4.2.4.4 SWOT Analysis
4.2.4.5 Business Strategy
4.2.5 ViewRay Technologies
4.2.5.1 Overview
4.2.5.2 Product Portfolio
4.2.5.3 Financial Analysis
4.2.5.4 SWOT Analysis
4.2.5.5 Business Strategy
4.3 Top Winning Strategies by Market Players
4.3.1 Merger and Acquisition
4.3.2 Product Launch
4.3.3 Partnership and Collaboration
- Global Radiotherapy Market Sales Analysis by Product Type ($ Million)
5.1 External Beam Radiotherapy (EBRT) Systems
5.2 Internal Radiotherapy (Brachytherapy) Systems
5.3 Radiotherapy Software
5.4 Radiotherapy Accessories
- Global Radiotherapy Market Sales Analysis by Technology ($ Million)
6.1 Intensity-Modulated Radiotherapy (IMRT)
6.2 Image-Guided Radiotherapy (IGRT)
6.3 Stereotactic Radiotherapy (SRT/SBRT)
6.4 Proton Beam Therapy
6.5 3D Conformal Radiotherapy (3D-CRT)
- Global Radiotherapy Market Sales Analysis by Application ($ Million)
7.1 Breast Cancer
7.2 Lung Cancer
7.3 Prostate Cancer
7.4 Colorectal Cancer
7.5 Head & Neck Cancer
7.6 Brain Tumors
7.7 Cervical Cancer
7.8 Others
- Global Radiotherapy Market Sales Analysis by End User ($ Million)
8.1 Hospitals
8.2 Independent Radiotherapy Centers
8.3 Academic & Research Institutes
- Regional Analysis
9.1 North American Radiotherapy Market Sales Analysis – Product Type | Technology | Application | End User | Country ($ Million)
9.1.1 United States
9.1.2 Canada
9.2 European Radiotherapy Market Sales Analysis – Product Type | Technology | Application | End User | Country ($ Million)
9.2.1 UK
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 France
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Asia-Pacific Radiotherapy Market Sales Analysis – Product Type | Technology | Application | End User | Country ($ Million)
9.3.1 China
9.3.2 Japan
9.3.3 South Korea
9.3.4 India
9.3.5 Australia & New Zealand
9.3.6 ASEAN Countries
9.3.7 Rest of Asia-Pacific
9.4 Rest of the World Radiotherapy Market Sales Analysis – Product Type | Technology | Application | End User | Country ($ Million)
9.4.1 Latin America
9.4.2 Middle East and Africa
- Company Profiles
10.1 Best Medical International (TeamBest)
10.1.1 Quick Facts
10.1.2 Company Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.2 Brainlab AG
10.2.1 Quick Facts
10.2.2 Company Overview
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.3 C. R. Bard (BD)
10.3.1 Quick Facts
10.3.2 Company Overview
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.4 Eckert & Ziegler (BEBIG Medical)
10.4.1 Quick Facts
10.4.2 Company Overview
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.5 GE HealthCare (MIM Software)
10.5.1 Quick Facts
10.5.2 Company Overview
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.6 Hitachi, Ltd.
10.6.1 Quick Facts
10.6.2 Company Overview
10.6.3 Product Portfolio
10.6.4 Business Strategies
10.7 IsoRay Medical
10.7.1 Quick Facts
10.7.2 Company Overview
10.7.3 Product Portfolio
10.7.4 Business Strategies
10.8 LinaTech
10.8.1 Quick Facts
10.8.2 Company Overview
10.8.3 Product Portfolio
10.8.4 Business Strategies
10.9 Mevion Medical Systems
10.9.1 Quick Facts
10.9.2 Company Overview
10.9.3 Product Portfolio
10.9.4 Business Strategies
10.10 Panacea Medical Technologies
10.10.1 Quick Facts
10.10.2 Company Overview
10.10.3 Product Portfolio
10.10.4 Business Strategies
10.11 P-Cure
10.11.1 Quick Facts
10.11.2 Company Overview
10.11.3 Product Portfolio
10.11.4 Business Strategies
10.12 PTW Freiburg
10.12.1 Quick Facts
10.12.2 Company Overview
10.12.3 Product Portfolio
10.12.4 Business Strategies
10.13 RaySearch Laboratories AB
10.13.1 Quick Facts
10.13.2 Company Overview
10.13.3 Product Portfolio
10.13.4 Business Strategies
10.14 RefleXion Medical
10.14.1 Quick Facts
10.14.2 Company Overview
10.14.3 Product Portfolio
10.14.4 Business Strategies
10.15 Shinva Medical Instrument Co., Ltd.
10.15.1 Quick Facts
10.15.2 Company Overview
10.15.3 Product Portfolio
10.15.4 Business Strategies
10.16 Standard Imaging, Inc.
10.16.1 Quick Facts
10.16.2 Company Overview
10.16.3 Product Portfolio
10.16.4 Business Strategies
10.17 Sumitomo Heavy Industries, Ltd.
10.17.1 Quick Facts
10.17.2 Company Overview
10.17.3 Product Portfolio
10.17.4 Business Strategies
10.18 Sun Nuclear (A Mirion Medical Company)
10.18.1 Quick Facts
10.18.2 Company Overview
10.18.3 Product Portfolio
10.18.4 Business Strategies
10.19 Theragenics Corporation
10.19.1 Quick Facts
10.19.2 Company Overview
10.19.3 Product Portfolio
10.19.4 Business Strategies
10.20 Xstrahl
10.20.1 Quick Facts
10.20.2 Company Overview
10.20.3 Product Portfolio
10.20.4 Business Strategies
1. Global Radiotherapy Market Research and Analysis by Product Type, 2025–2035 ($ Million)
2. Global External Beam Radiotherapy (EBRT) Systems Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Internal Radiotherapy (Brachytherapy) Systems Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Radiotherapy Software Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Radiotherapy Accessories Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Radiotherapy Market Research and Analysis by Technology, 2025–2035 ($ Million)
7. Global Intensity-Modulated Radiotherapy Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Image-Guided Radiotherapy Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Stereotactic Radiotherapy Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Proton Beam Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global 3D Conformal Radiotherapy Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Radiotherapy Market Research and Analysis by Application, 2025–2035 ($ Million)
13. Global Radiotherapy For Breast Cancer Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Radiotherapy For Lung Cancer Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Radiotherapy For Prostate Cancer Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Radiotherapy Market Research and Analysis by End User, 2025–2035 ($ Million)
17. Global Radiotherapy For Hospitals Market Research and Analysis by Region, 2025–2035 ($ Million)
18. Global Radiotherapy For Independent Radiotherapy Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
19. Global Radiotherapy For Academic & Research Institutes Market Research and Analysis by Region, 2025–2035 ($ Million)
20. Global Radiotherapy Market Research and Analysis by Region, 2025–2035 ($ Million)
1. Global Radiotherapy Market Share by Product Type, 2025 Vs 2035 (%)
2. Global External Beam Radiotherapy (EBRT) Systems Radiotherapy Market Share by Region, 2025 Vs 2035 (%)
3. Global Internal Radiotherapy Radiotherapy Market Share by Region, 2025 Vs 2035 (%)
4. Global Radiotherapy Software Radiotherapy Market Share by Region, 2025 Vs 2035 (%)
5. Global Radiotherapy Market Share by Technology, 2025 Vs 2035 (%)
6. Global IMRT Radiotherapy Market Share by Region, 2025 Vs 2035 (%)
7. Global IGRT Radiotherapy Market Share by Region, 2025 Vs 2035 (%)
8. Global Radiotherapy Market Share by Application, 2025 Vs 2035 (%)
9. Global Radiotherapy For Breast Cancer Share by Region, 2025 Vs 2035 (%)
10. Global Radiotherapy For Lung Cancer Share by Region, 2025 Vs 2035 (%)
11. Global Radiotherapy Market Share by End User, 2025 Vs 2035 (%)
12. Global Radiotherapy Market Share by Region, 2025 Vs 2035 (%)
13. United States Radiotherapy Market Size, 2025–2035 ($ Million)
14. Canada Radiotherapy Market Size, 2025–2035 ($ Million)
15. UK Radiotherapy Market Size, 2025–2035 ($ Million)
16. France Radiotherapy Market Size, 2025–2035 ($ Million)
17. Germany Radiotherapy Market Size, 2025–2035 ($ Million)
18. Italy Radiotherapy Market Size, 2025–2035 ($ Million)
19. Spain Radiotherapy Market Size, 2025–2035 ($ Million)
20. Russia Radiotherapy Market Size, 2025–2035 ($ Million)
21. India Radiotherapy Market Size, 2025–2035 ($ Million)
22. China Radiotherapy Market Size, 2025–2035 ($ Million)
23. Japan Radiotherapy Market Size, 2025–2035 ($ Million)
24. South Korea Radiotherapy Market Size, 2025–2035 ($ Million)
25. Australia & New Zealand Radiotherapy Market Size, 2025–2035 ($ Million)
26. ASEAN Radiotherapy Market Size, 2025–2035 ($ Million)
27. Rest of Asia-Pacific Radiotherapy Market Size, 2025–2035 ($ Million)
28. Latin America Radiotherapy Market Size, 2025–2035 ($ Million)
29. Middle East & Africa Radiotherapy Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
